Translate
Ensysce Biosciences Inc
About
Ensysce Biosciences Inc (NASDAQ:ENSC) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
Apr 7 2026
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
Mar 30 2026
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4 2026
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
Mar 3 2026
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology